SURGICAL HEMOSTATS, INTERNAL TISSUE SEALANTS, AND ADHESION BARRIERS MARKET ANALYSIS

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type (Hemostats (Thrombin Based, Combination Hemostats, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based), Internal Tissue Sealants (Fibrin Based, Collagen Based, Protein Based, Synthetic Polymer Based), Adhesion Barriers (Film Based, Gel Based, Solution Based)), By Application (Surgical Applications (Cardiovascular Surgeries, Neurological Surgeries, Orthopedic Surgeries, Urological & Gynecological Surgeries, General Surgeries, Reconstructive, and Plastic Surgeries, Others), Trauma Cases), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2023
Code : CMI3721
Pages :171
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market - Key Players

Major players operating in the global surgical hemostats, internal tissue sealants, and adhesion barriers market include Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring